Brainz Instruments , Ltd.

Brainz Instruments, Ltd. specializes in brain monitoring devices, specifically the BRM2 Brain Monitor and BRM3 Brain Monitor. These devices are engineered for continuous neurological assessment in clinical environments, helping healthcare providers track brain function in real-time.

Brainz Instruments, Ltd. is headquartered in the United States. The company’s location ensures it operates within the regulatory framework of the FDA, which governs its device authorizations.

Brainz Instruments, Ltd.’s devices are listed in the FDA’s 510(k) registry. This pathway is used for Class II devices, which require pre-market notification to demonstrate substantial equivalence to a legally marketed predicate device before commercial distribution.

Brainz Instruments, Ltd.’s devices, including the BRM2 and BRM3 Brain Monitors, fall under Class II classification. This classification is assigned based on the risk level of the device, where moderate controls are required to ensure safety and effectiveness. Class II devices typically undergo a 510(k) review to confirm they meet regulatory standards.